Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B0e3f11ec872ab483349db8c8f33f8bf1> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B0e3f11ec872ab483349db8c8f33f8bf1 NCIT_P378 "NCI" @default.
- B0e3f11ec872ab483349db8c8f33f8bf1 type Axiom @default.
- B0e3f11ec872ab483349db8c8f33f8bf1 annotatedProperty IAO_0000115 @default.
- B0e3f11ec872ab483349db8c8f33f8bf1 annotatedSource NCIT_C64620 @default.
- B0e3f11ec872ab483349db8c8f33f8bf1 annotatedTarget "A fully human IgG1 monoclonal antibody against epidermal growth factor receptor (EGFR) with potential antineoplastic activity. EGFR is a cell surface receptor tyrosine kinase, overexpressed on many cancer cells. Zalutumumab selectively binds to and blocks binding of EGF and transforming growth factor-alpha (TGF-a) to the EGFR receptor, thereby interfering with cellular signaling, leading to cell growth inhibition and apoptosis in tumor cells. In addition, zalutumumab also triggers cell lysis mediated through antibody dependent cellular cytotoxicity (ADCC) in EGFR-expressing cells." @default.